Following yesterday’s post, I came across this article in today’s Globe and Mail. The article talks about a vaccine for cattle that would reduce the risk of E. coli to consumers that has been developed by a Canadian company, Bioniche Life Sciences Inc.
Bioniche has a food safety division, which (according to its website) “is responsible for researching, developing, manufacturing, and marketing veterinary biopharmaceutical products to address diseases in livestock which may have an effect on human health”. Now that’s what I’m talking about – Bravo!
Bioniche is trying to get the federal government to vaccinate all Canadian cattle (to the tune of approximately $50-million yearly). The government is balking at the price tag because (according to the government) key industry players aren’t convinced the science supports the success of the vaccine, and because of logistical concerns. Some say that money would be better spent educating Canadians on how to properly handle and cook meat.
So where does this leave us? It looks like there may be something to Bioniche’s vaccine, but that further study (including its effects in humans) is needed.
Where would you prefer the government invest – in working with Bioniche to demonstrate the safety and efficacy of the vaccine (and making improvements if needed), or in educating Canadians on proper meat protocol?
For what it’s worth, my money’s with the vaccine.